期刊文献+

丹参多酚盐治疗多脏器功能不全的实验研究 被引量:4

The Therapeutic Effects of Salvianolate Injection Against Multiple Organ Dysfunction Syndrome
下载PDF
导出
摘要 目的:探讨丹参多酚盐体内治疗多脏器功能不全的作用。方法:健康大耳白兔24只,随机分为正常对照组、内毒素组、丹参多酚盐干预组,每组8只。内毒素组经耳缘静脉静推LPS(1ml/kg),12h后再由耳缘静脉注射一次LPS(1ml/kg),复制SIRS/MODS动物模型;对照组耳缘静脉静推等量生理盐水;丹参多酚盐干预组于0h,12h经耳缘静脉推注LPS(1ml/kg)并于第一次注入内毒素后6h,12h,18h静推丹参多酚盐(50mg/kg)。于24h时间点测定各组动物血清肿瘤坏死因子-α(TNF-α)、白细胞介素-1(IL-1)、白细胞介素-6(IL-6)、血小板活化因子(PAF)。光镜下观察各组动物脏器病理学变化。结果:丹参多酚盐干预组与内毒素组相比,IL-1、IL-6、PAF、TNF-α均较内毒素组有不同程度降低。丹参多酚盐干预组脏器损伤组织学改变较内毒素组明显减轻。结论:丹参多酚盐具有治疗多脏器功能不全的作用,为防治MODS提供了实验依据。 Objective: To observe the therapeutic effect of Salvianolate injection against multiple organ dysfunction syndrome(MODS). Methods: 24 rabbits were randomly divided into three groups: control group (n= 8), MODS group (n= 8), treatment group (n= 8). The MODS group were given endotoxin (1mL · kg^-1) twice at 0, 12 hours timepoint; the control group were given injection of normal saline (1mL · kg^-1), and the treatment group were given Salvianolate injection (300mg · kg ^-1) 3 times at 6,12, 18 hours timepoints besides the injection of endotoxin (1 mL · kg^-1). The serum concentration of TNF-α, IL-1, IL-6, PAF were measured at 24 hours time points. The pathological changes were observed under microscope. Results: TNF-α, 1L-1, IL-6, PAF concentrations of the treatment group were significant different from those of control group and injury group. Pathology showed Salvianolate intervention group reduced lung and renal injury. Conclusion: Salvianolate injection has therapeutic effect against multiple organ dysfunction syndrome.
出处 《数理医药学杂志》 2010年第1期43-45,共3页 Journal of Mathematical Medicine
关键词 多脏器功能不全综合症 丹参多酚盐注射液 内毒素 炎症介质 multiple organ dysfunction syndrome (MODS) salvianolate injection endotoxin inflammatory mediator
  • 相关文献

参考文献6

  • 1Malleo G, Mazzon E, Siriwardena AK, et al. Role of tumor necro sis factor alpha in acute pancreatitis: from biological basis to clinical evidence. Shock,2007,28(2) : 130-140.
  • 2Taniguehi T, Kidani Y, Kanakura H, et al. Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin- induced shock in rats. Crit Care Med,2004, 32(6):1322-1326.
  • 3Bohrer H, Qiu F, Zimmermann T, et al. Role of NFkappaB in the mortality of sepsis. J Clin Invest, 1997,100(5) : 972-985.
  • 4Kim PK, Deutschman CS. Inflammatory responses and mediators. Surg Clin North Am,2000,80(3):885-894.
  • 5Prescott SM, Mclntyre TM, Zimmerman GA. Platelet-activating factor: a phospholipid mediator of inflammation. In Inflammation: Basic Principles and Clinical Correlates, Gallin JI, Snyderman R. Lippincott Williams & Wilkins: Philadelphia, PA, 1999, 387-389.
  • 6唐皓,熊艳,李玉杰,詹红,彭延文,荆小莉,梁艳冰,叶海宁,马中富.SIRS与MODS患者外周血单核细胞环氧化酶与血小板活化因子的关系研究[J].中国危重病急救医学,2006,18(11):687-690. 被引量:3

二级参考文献13

  • 1王今达,王宝恩.多脏器功能失常综合征(MODS)病情分期诊断及严重程度评分标准(经庐山’95全国危重病急救医学学术会讨论通过)[J].中国危重病急救医学,1995,7(6):346-347. 被引量:1422
  • 2梁艳冰,陈娟,马中富,唐皓,叶海宁,熊艳,詹红.多器官功能障碍综合征患者外周血单个核细胞凋亡的研究[J].中国危重病急救医学,2006,18(2):101-104. 被引量:6
  • 32001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference[J].Crit Care Med,2003,31:1250-1256.
  • 4孙卫民,王惠琴.细胞因子研究方法学[M].第2版.北京:人民卫生出版社,2000:143-144.
  • 5Sorli C H,Zhang H J,Armstrong M B,et al.Basal expression of cyclooxygenase2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin-1 in the pancreatic islet[J].Proc Natl Acad Sci USA,1998,95:1788-1793.
  • 6Rangel E B,Moura L A,Franco M F,et al.Up-regulation of cyclooxygenase-2 during acute human renal allograft rejection[J].Clin Transplant,2005,19:543-550.
  • 7Inoue T,Sugimoto A,Suzuki Y,et al.TypeⅡ platelet-activating factor-acetylhydrolase is essential for epithelial morphogenesis in Caenorhabditis elegans[J].Proc Natl Acad Sci USA,2004,101:13233-13238.
  • 8Osoegawa M,Niino M,Ochi H,et al.Platelet-activating factor acetylhydrolase gene polymorphism and its activity in Japanese patients with multiple sclerosis[J].J Neuroimmunol,2004,150:150-156.
  • 9Martey C A,Pollock S J,Turner C K,et al.Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts:implications for lung inflammation and cancer[J].Am J Physiol Lung Cell Mol Physiol,2004,287:L981-991.
  • 10Sadikot R T,Christman J W,Blaokwell T S.Molecular tagets for modulating lung inflammation and injury[J].Curr Drug Targets,2004,5:581-588.

共引文献2

同被引文献71

引证文献4

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部